Average Diluted Shares Outstanding: 243 million, 1% lower than a year ago. Cardinal Health Inc (NYSE:CAH) reported strong second quarter results, driven by robust demand in pharmaceutical and ...

Cardinal Health (CAH) ended the recent trading session at $124.71, demonstrating a +0.55% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain ...

In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against other stocks to buy and sell highlighted in Jim Cramer’s latest calls. Jim Cramer in a ...

In a report released yesterday, Stephen Baxter from Wells Fargo maintained a Hold rating on Cardinal Health (CAH – Research Report), with a price target of $135.00. The company’s shares closed ...

CAH is a #2 (Buy) on the Zacks Rank, with a VGM Score of A. It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 16.3; value investors should ...

Cardinal Health, Inc. CAH reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.93, which beat the Zacks Consensus Estimate of $1.75 by 10.3%. The bottom line also improved 2 ...

SINGAPORE – The Toa Payoh warehouse where a unit’s mezzanine floor collapsed on Jan 28 is structurally safe, the Building and Construction Authority (BCA) has said. In response to a query from ...

At the heart of this guide by Lawton Solutions is the CRAFT framework, a step-by-step AI prompting method designed to make writing prompts easier, clearer, and more effective. By focusing on key ...

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...

SINGAPORE: A major upcoming sports and community project in Singapore's central Toa Payoh residential town will supplement the country's main Kallang Alive sporting precinct, according to ...

CAH, a group of genetic disorders affecting adrenal glands, is characterized by excessive levels of androstenedione (A4), a steroid and key disease biomarker. Crinetics (NASDAQ:CRNX) has designed ...

For the second time in less than a year, Joann Inc. filed for Chapter 11 bankruptcy protection. This time, it's also trying to sell itself to another company in an effort to "maximize the value of ...